We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Monoclonal Antibodies Specific to Mycoplasma genitalium Available

By LabMedica International staff writers
Posted on 12 Jul 2012
A set of four monoclonal antibodies that are specific to Mycoplasma genitalium has been released. They do not cross react with other Mycloplasmas and/or related bacteria.

The antibodies function in the enzyme-linked immunosorbent assay (ELISA) and indirect fluorescence assay (IFA) and are available for research and assay development.

Mycoplasma genitalium is a small bacterium without a cell wall. It resides in the human urogenital tract where it obtains its nutrients and causes urethritis in males and females as well as pelvic inflammatory disease (PID) in females.

ViroStat (Portland, ME, USA) released the four monoclonal antibodies. These may be used for assay development but meanwhile they are not yet available for diagnostic purposes. The data sheet, including pricing, for the antibodies can be found at the ViroStat website.

ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies. These include high affinity antibodies to Flu A, Flu B, Respiratory syncytial virus (RSV) and Streptococcus A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to Hepatitis C virus (HCV), Hepatitis B virus (HBV), Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are available for use in antiviral high-throughput screening assays (HTS) assays.

Related Links:

ViroStat



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Thyroid Test
Anti-Thyroid EIA Test
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control

Latest Immunology News

Immune Biomarkers May Predict Recurrent Checkpoint Inhibitor Arthritis
12 Jul 2012  |   Immunology

Immune Cell Blood Test May Predict Melanoma Immunotherapy Response
12 Jul 2012  |   Immunology

Study Reveals Viral Protein Driving COVID-19-Related Vascular Injury
12 Jul 2012  |   Immunology